News

Biotech's Boom Suffers a Setback in March April 01, 2014 | Press Release

Investors Flock to Biotech March 03, 2014 | Press Release

Biotech IPOs Off to a Strong Start in 2014 February 03, 2014 | Press Release

  See all News
 
Sign up for a free subscription to The Burrill Weekly Brief 
Sign up to receive email notifications about our upcoming events and news.



David C. Parke

Managing Director

David Parke joined Burrill Securities in June 2011 as a managing director. Mr. Parke specializes in public offerings, private placements, fairness opinions, and mergers and acquisitions for emerging-growth companies. His experience delivers a strong background in capital markets with an in-depth understanding of the issues particular to life sciences and healthcare companies.
Mr. Parke joined Burrill Securities from Boenning & Scattergood. Prior to that, he was with Mufson Howe Hunter & Company for three years, where he was instrumental in launching and developing the firm's emerging growth practice. He was previously with the corporate finance department of Investec, Inc. and its predecessor, Pennsylvania Merchant Group. Mr. Parke has managed or participated in 40 public offerings and private placements, raising more than $1 billion for emerging growth clients. In addition, he has managed mergers and acquisitions assignments ranging from $5 million to $500 million. Prior to joining Investec in 1992, he was in the corporate finance departments of Wheat First Butcher & Singer, now Wachovia Securities, and Legg Mason.
He has been a director of Petroleum Development Corporation, a publicly-traded natural gas exploration and production company, since 2003. He chairs the board's Finance and Planning Committee, and is a member of its Compensation and Audit Committees.
Mr. Parke received his MBA with Honors from The Wharton School of the University of Pennsylvania, and graduated summa cum laude and Phi Beta Kappa from Lehigh University with a B.S. in Finance.